New York's health commissioner has described the state's measles outbreak as a disaster that could have been prevented. The spread has renewed attention on MMR vaccination rates and the public health measures needed to contain transmission.
11:00 AMGothamist11 stories from 8 sources
Public health systems face preventable spread and new demands
Day’s Recap
Supporting Articles

Google announced a women's health partnership with Flo Health, a platform used by more than 80 million women each month, alongside the launch of a new Fitbit. The collaboration aims to combine women's health information with wearable-based tracking and guidance.
2:21 PMPYMNTS
Pope Leo is scheduled to undergo surgery in Rome to remove a lung nodule and is expected to remain hospitalized for about a week. The procedure comes ahead of a planned tour of Latin America.
3:06 PMAl Jazeera
Pope Leo is continuing his work after the announcement that he will undergo lung surgery. The report offers no further details on the procedure or its expected impact on his schedule.
12:10 PMAl JazeeraNY measles spread prompts 'disaster' emergency. It didn't have to be this way, health commissioner says.
Summary
New York's health commissioner has described the state's measles outbreak as a disaster that could have been prevented. The spread has renewed attention on MMR vaccination rates and the public health measures needed to contain transmission.
The state's emergency response reflects a failure to maintain sufficient vaccination coverage before measles spread.
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The outbreak shows how declining vaccination coverage can turn a preventable disease into a statewide public health emergency.

Google Launches Women’s Health Partnership and New Fitbit
Summary
Google announced a women's health partnership with Flo Health, a platform used by more than 80 million women each month, alongside the launch of a new Fitbit. The collaboration aims to combine women's health information with wearable-based tracking and guidance.
The partnership gives Google access to a large women's health platform while extending Fitbit's role
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The deal could help normalize integrated women's health tracking while testing whether users trust technology companies with highly sensitive data.

Pope Leo to undergo surgery to remove lung nodule in Rome
Summary
Pope Leo is scheduled to undergo surgery in Rome to remove a lung nodule and is expected to remain hospitalized for about a week. The procedure comes ahead of a planned tour of Latin America.
The operation creates immediate uncertainty around the pope's recovery and travel schedule. A weeklong hospitalization
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The pope's health could affect the Vatican's public schedule and the logistics of an upcoming international visit.

Pope Leo continues working after lung surgery announcement
Summary
Pope Leo is continuing his work after the announcement that he will undergo lung surgery. The report offers no further details on the procedure or its expected impact on his schedule.
The decision to maintain work signals that the Vatican is treating the surgery as compatible
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The pope's health can directly shape the Vatican's public calendar and its ability to carry out high-profile religious and diplomatic engagements.
Other Developments
A curated list of other prominent stories from this day.

Comedian and YouTuber Grace Helbig said doctors found two brain tumors after she went to the emergency room with numbness in her legs. The diagnosis comes three years after she completed treatment for breast cancer, and she is preparing for surgery.
3:26 PMVariety
Psychedelic medicines now moving through development differ sharply from the unregulated drugs associated with the 1970s. They are being tested in rigorous clinical trials and produced through licensed manufacturing processes, but the U.S. still needs supporting infrastructure as the field advances.
8:35 AMFortune
Users of GLP-1 weight loss drugs showed unexpectedly high rates of nail detachment, hair loss, and scalp inflammation. Weight loss alone did not fully account for the differences, pointing to possible treatment-related effects that warrant further study.
5:34 AMScienceDaily
The study links declining Menin levels to several age-related changes and reports that restoring the protein reversed those changes in older mice over 30 days. D-serine supplementation also improved memory and learning in mice.
5:23 AMScienceDaily
Dr. Peter Piot reflects on seeing the Ebola virus under a microscope five decades ago and on a career spent confronting Ebola and another deadly pathogen. His account connects that discovery to continuing concerns about infectious disease threats.
5:02 AMThe New York Times
Elon University's Charlotte campus presents a model for linking physician assistant education with community health needs. The approach treats PA training as part of a broader workforce strategy rather than a standalone solution to clinician shortages.
5:00 AMHigher Ed Dive
Researchers found that vanillin, the compound responsible for vanilla's flavor, has antimicrobial, anti-inflammatory, and wound-healing properties in experimental studies. They suggest it could eventually contribute to advanced wound treatments and regenerative medicine.
12:34 AMScienceDaily
Grace Helbig Reveals Upcoming Surgery for Brain Tumors Three Years After Beating Breast Cancer
Summary
Comedian and YouTuber Grace Helbig said doctors found two brain tumors after she went to the emergency room with numbness in her legs. The diagnosis comes three years after she completed treatment for breast cancer, and she is preparing for surgery.
The new neurological symptoms revealed a second cancer-related medical crisis after Helbig's earlier breast cancer
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Helbig's diagnosis shows that completing one cancer treatment does not end the need for ongoing monitoring and rapid evaluation of new symptoms.

Psychedelic medicine is approaching a turning point. The U.S. needs the right infrastructure to be ready
Summary
Psychedelic medicines now moving through development differ sharply from the unregulated drugs associated with the 1970s. They are being tested in rigorous clinical trials and produced through licensed manufacturing processes, but the U.S. still needs supporting infrastructure as the field advances.
Clinical validation and controlled manufacturing are moving psychedelics closer to mainstream medicine, but approval alone
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The next bottleneck for psychedelic medicine may be healthcare infrastructure rather than scientific legitimacy.

Popular weight loss drugs linked to a surprising fingernail problem
Summary
Users of GLP-1 weight loss drugs showed unexpectedly high rates of nail detachment, hair loss, and scalp inflammation. Weight loss alone did not fully account for the differences, pointing to possible treatment-related effects that warrant further study.
The findings expand the safety discussion beyond the drugs' common gastrointestinal effects and metabolic benefits.
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Patients may stop effective therapies if visible skin, hair, or nail problems are not anticipated and properly managed.

Scientists find hidden driver of aging and a simple amino acid that fights memory loss in mice
Summary
The study links declining Menin levels to several age-related changes and reports that restoring the protein reversed those changes in older mice over 30 days. D-serine supplementation also improved memory and learning in mice.
The findings point to two testable targets for age-related decline, but they remain preclinical. Results
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
If the biology translates to humans, the work could open new approaches to treating aging-related cognitive decline rather than managing symptoms alone.

He Helped Discover Ebola 50 Years Ago. He’s Still Worried.
Summary
Dr. Peter Piot reflects on seeing the Ebola virus under a microscope five decades ago and on a career spent confronting Ebola and another deadly pathogen. His account connects that discovery to continuing concerns about infectious disease threats.
The lasting lesson is that identifying a pathogen does not end the risk it poses.
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The next outbreak will test whether governments have maintained the systems needed to detect and contain dangerous pathogens quickly.

More PAs is only part of the answer to the healthcare workforce shortage
Summary
Elon University's Charlotte campus presents a model for linking physician assistant education with community health needs. The approach treats PA training as part of a broader workforce strategy rather than a standalone solution to clinician shortages.
The key issue is not simply producing more PAs, but directing training toward communities and
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Healthcare systems need workforce programs that change where and how care is delivered, not just the number of graduates.

Scientists discover vanilla’s hidden healing potential
Summary
Researchers found that vanillin, the compound responsible for vanilla's flavor, has antimicrobial, anti-inflammatory, and wound-healing properties in experimental studies. They suggest it could eventually contribute to advanced wound treatments and regenerative medicine.
The result identifies a cheap, accessible molecule as a possible starting point for new wound-care
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
An inexpensive compound with multiple wound-care effects could be valuable where advanced therapies are costly or unavailable.
Make it yours
Build Your First Pass.
Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!